You reviewed ....
for this content
out of 5
Select Select events(s)
Select Resource type(s)
Presentations below are part of sessions sponsored by Bayer
Update on CMR in patients recovering from Covid-19 infection.
Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.
ESC Congress 2020
Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.
Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?
How can we protect patients long-term after a percutaneous coronary intervention (PCI)?
Live Questions and Answers and closing.
New insights from a deep dive into VICTORIA data and its potential impacts.
Optimizing protection for patients with symptomatic chronic peripheral artery disease.
Get your access to resources
Our mission: To reduce the burden of cardiovascular disease